HM
AUPH icon

HealthCor Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

HealthCor Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-950,000
Closed -$12.3M – 78
2021
Q1 		$12.3M Sell
950,000
-5,987,448
-86% -$86.9M 0.44% 51
2020
Q4 		$95.9M Sell
6,937,448
-1,936,505
-22% -$28.2M 3.7% 7
2020
Q3 		$131M Sell
8,873,953
-627,445
-7% -$9.09M 5.23% 7
2020
Q2 		$154M Sell
9,501,398
-262,522
-3% -$4.2M 6.47% 1
2020
Q1 		$142M Buy
9,763,920
+4,943,590
+103% +$87.2M 6.06% 3
2019
Q4 		$97.7M Buy
4,820,330
+3,987,960
+479% +$36.7M 3.48% 9
2019
Q3 		$4.45M Buy
+832,370
New +$5.04M 0.17% 49

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HealthCor Management's AUPH Position: Q2 2021 in Review

HealthCor Management sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2021, closing a stake of 950,000 shares — an estimated $12.3M sold.

HealthCor Management first reported a position in AUPH in Q3 2019 and held it in 7 quarters. The position peaked at $154M in Q2 2020. 167 funds tracked by Wall St. Rank hold AUPH as of Q2 2021.

  • HealthCor Management reported no remaining Aurinia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • HealthCor Management sold 950,000 Aurinia Pharmaceuticals shares in Q2 2021, an estimated $12.3M.
  • HealthCor Management first reported a position in Aurinia Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • HealthCor Management's Aurinia Pharmaceuticals position peaked at $154M in Q2 2020.
  • 167 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2021.

Based on HealthCor Management's 13F filing for Q2 2021, filed 16 Aug 2021.